Randox provide a wide range of diagnostic solutions, all designed to bring greater efficiency, cost-effectiveness and quality to your laboratory.
At MEDLAB Middle East we will be exhibiting a range of products including analysers, quality control material, reagents and biochip array technology.
Please see below for a selection of what we offer.
- Life Sciences
Randox Biosciences is dedicated to improving healthcare worldwide and has been for 35 years with an enthusiastic team who are continuing to pursue innovative projects to transform healthcare. We aim to advance scientific discovery, drug development and diagnostics. Spanning four key divisions: Life Sciences, Pharma Sciences, Research and Molecular; we supply high quality diagnostic solutions and quality raw materials to the pharmaceutical, clinical, life sciences and research industries.
Randox Molecular offers diagnostic, prognostic and predictive solutions across a variety of disease areas. Utilizing our innovative Biochip Array Technology with multiple PCR technology our molecular arrays produce rapid, precise results from one single sample for complete patient profiling and risk prediction.
Randox Life Sciences have been developing and manufacturing antibodies, recombinant proteins and conjugates for over 35 years. We offer an extensive off the shelf product range as well as custom antibody development services to suit your needs.
We are a trusted companion diagnostics partner with the ability to work with large pharmaceutical clients taking the drug development project from feasibility through to regulatory approval, with over 220 FDA cleared and over 700 CE marked assays. We cover a vast range of therapeutic areas including Oncology, Immunology, Metabolic, Nutritional, Cardiovascular, Cerebrovascular, Respiratory, Toxicology and Infection.
Randox Research offers a comprehensive range of technologies and solutions to universities globally. We are on hand to provide to help with a variety of research projects offering wide test menu and an unrivalled series of analysers from our RX to our Evidence helping to accelerate your projects.
Randox Biosciences is the world’s leading primary manufacturer of high quality antibodies, proteins and conjugates. We offer an extensive portfolio of over 900 products for a multitude of R&D applications including more than 500 monoclonal and polyclonal antibodies.
We offer over 60 monoclonal antibodies which offers excellent specificity with each batch consisting of a single antibody resulting in excellent specificity to the target compound. The antibodies also offer high affinity with each on binding to the target with the same affinity.
- Biochemical Markers: Biochemical messengers, Fatty Acid Binding Proteins and products with applications in the following therapeutic areas: Immunology, Oncology, cardiovascular/Cerebrovascular and Metabolic/Nutrition.
- Drugs of abuse: alcohol, anti-depressants, barbiturates, hallucinogens, opiates, stimulants
- Drug Residue: antimicrobial drugs, growth promoters, mycotoxins
Randox Biosciences has over 800 primary antibody products which are specific to a wide range of markers including:
- Biochemical Markers: Biochemical messengers, fatty acid binding proteins and products with applications in the following therapeutic areas: immunology, oncology, cardiovascular/cerebrovascular and metabolic/nutrition.
- Drugs of Abuse: Alcohol, Analgesics, Anti-depressants, Barbiturates, Benzodiazepines, Hallucinogens, Opiates, Sedatives, Stimulants, Synthetic Drugs, Therapeutic Drugs
Recombinant Antibody Fragments
Off the shelf offering hosts a range of recombinant fragments including Single Chain Variable Fragments (scFv) and Single Domain Antibodies (sdAb). Our scientists highly recommend the use of Single Domain Antibody Fragments (sdAb) as they are more stable, adaptable and easily humanised making the ideal for therapeutic products.
Human Recombinant Proteins
Randox Biosciences offer five human recombinant proteins specific to a wide range of biochemical markers and these include:
- Adhesion Molecules
- Tumour Markers
Frozen Human Plasma
Plasma is traditionally used for patient care, but 80% of donated plasma ends up going to waste. Human plasma is ideal for the production of control and calibrator material. Reagents in biochemical assays for research and development purposes. Our frozen human plasma is available in 3 different formats:
- Mixed Gender
The plasma is high screen for HIV, Hepatitis B&C, HTLV + II, Syphilis, CMV and Procleix WNV
Biochip Array Technology is the foundation for Randox multiplex molecular testing, enabling detection of up to 44 targets in a single patient sample. Currently the molecular product portfolio covers a variety of disease areas such as infectious disease, oncology and cardiovascular disease. Below are the current molecular arrays.
Familial Hypercholesterolemia (FH) Arrays I & II
The FH array detects 40 key inherited mutations within the LDLR, ApoB and PCSK9 genes which are associated with high cholesterol. This array is the ideal protocol for rapid, cost effective cascade testing in family members of FH index patient. The assay is based on a combination of multiplex PCR and biochip array hybridization. The array is CE marked for routine clinical testing.
Cardiac Risk Prediction Array
The cardiac risk prediction allows for the simultaneous genotyping of 20 SNPs within 1 day. Combining genotyping information with common risk factors can allow individuals to be more accurately classified therefore preventative therapies and lifestyle advice can be implemented.
Respiratory Infection Multiplex Array
This array is the most comprehensive test for infections of both the upper and lower respiratory tracts, detecting 22 bacterial and viral pathogens from a single sputum, lavage or nasopharyngeal sample. Analysis can be completed from template DNA and RNA through PCR to data readout in less than 6 hours. The array is CE marked for routine clinical testing.
Sexually Transmitted Infection (STI) Multiplex Array
The Sexually Transmitted Infection (STI) Multiplex Array simultaneously detects 10 bacterial, viral and protozoan infections including primary, secondary and asymptomatic co-infections for a complete infection profile. The array is CE marked for routine clinical use. The array is CE marked for routine clinical testing.
KRAS, BRAF, PIK3CA* Multiplex Array
This array detects simultaneously detects 20 mutations within the KRAS, BRAF and PIK3CA genes. This assay is validated for use with DNA extracted from fresh/frozen and formalin fixed paraffin embedded tissue. Analysis can be completed form a template DNA through PCR to date readout in less than 3 hours. This array primarily designed for colorectal cancer has implications for mutation screening in other cancer types. The array is CE marked for routine clinical testing.
We are a trusted companion diagnostics partner with the ability to work with large pharmaceutical clients taking the drug development project from feasibility through to regulatory approval, incorporating over 220 FDA cleared and over 700 CE marked assays. We cover a vast range of therapeutic areas including Oncology, Immunology, Metabolic, Nutritional, Cardiovascular, Cerebrovascular, Respiratory, Toxicology and Infection
Our CDx services provide global distributions and operations in over 145 countries ensuring no block to commercial adoption of the CDx. The companion diagnostic process is made easier with help from our expertise in custom assay development.
Custom Assay Development
For over 35 years, Randox Biosciences has been providing custom assay design, development and manufacturing services to the diagnostic, pharmaceutical, contract research and biotech industries. This also includes fully customised human and animal quality control sera and calibrators.
Clients can select either individual or multiple analytes from our current A-Z Menu, containing an impressive 380 clinical and research biomarkers.
Randox Biosciences assay development specialists will endeavor to work with you to ensure your needs are constantly met providing a smooth process from initial enquiry through to final delivery, following the steps outlined.